Literature DB >> 24848256

The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota.

Maria L Balmer1, Emma Slack1, Andrea de Gottardi1, Melissa A E Lawson1, Siegfried Hapfelmeier2, Luca Miele3, Antonio Grieco3, Hans Van Vlierberghe4, René Fahrner1, Nicola Patuto1, Christine Bernsmeier5, Francesca Ronchi1, Madeleine Wyss1, Deborah Stroka1, Nina Dickgreber6, Markus H Heim5, Kathy D McCoy1, Andrew J Macpherson7.   

Abstract

A prerequisite for establishment of mutualism between the host and the microbial community that inhabits the large intestine is the stringent mucosal compartmentalization of microorganisms. Microbe-loaded dendritic cells trafficking through lymphatics are arrested at the mesenteric lymph nodes, which constitute the firewall of the intestinal lymphatic circulation. We show in different mouse models that the liver, which receives the intestinal venous blood circulation, forms a vascular firewall that captures gut commensal bacteria entering the bloodstream during intestinal pathology. Phagocytic Kupffer cells in the liver of mice clear commensals from the systemic vasculature independently of the spleen through the liver's own arterial supply. Damage to the liver firewall in mice impairs functional clearance of commensals from blood, despite heightened innate immunity, resulting in spontaneous priming of nonmucosal immune responses through increased systemic exposure to gut commensals. Systemic immune responses consistent with increased extraintestinal commensal exposure were found in humans with liver disease (nonalcoholic steatohepatitis). The liver may act as a functional vascular firewall that clears commensals that have penetrated either intestinal or systemic vascular circuits.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2014        PMID: 24848256     DOI: 10.1126/scitranslmed.3008618

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  151 in total

Review 1.  The Microbiome, Systemic Immune Function, and Allotransplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 3.  Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.

Authors:  Maayan Levy; Christoph A Thaiss; Meirav N Katz; Jotham Suez; Eran Elinav
Journal:  Semin Immunopathol       Date:  2014-10-15       Impact factor: 9.623

4.  The Microbiota: A Microbial Ecosystem Built on Mutualism Prevails.

Authors:  Christoph Reinhardt
Journal:  J Innate Immun       Date:  2019-06-20       Impact factor: 7.349

Review 5.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

Review 6.  Gut-liver axis at the frontier of host-microbial interactions.

Authors:  Katharina Brandl; Vipin Kumar; Lars Eckmann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-23       Impact factor: 4.052

Review 7.  Liver macrophages in healthy and diseased liver.

Authors:  Zeinab Abdullah; Percy A Knolle
Journal:  Pflugers Arch       Date:  2017-03-14       Impact factor: 3.657

Review 8.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

Review 9.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

Review 10.  Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.

Authors:  Luca Miele; Valentina Giorgio; Maria Adele Alberelli; Erica De Candia; Antonio Gasbarrini; Antonio Grieco
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.